Dilday Tinslee, Ramos Nicole, Yeh Elizabeth
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Oncoscience. 2020 May 5;7(5-6):30-33. doi: 10.18632/oncoscience.504. eCollection 2020 May.
Once metastatic disease has occurred, there is no cure for breast cancer. Consequently, identifying factors that promote and support breast cancer metastasis is critical for understanding how to pharmacologically target this process. Hormonally up-regulated neu-associated kinase (HUNK) is a serine/threonine protein kinase related to the sucrose non-fermenting-1 (Snf-1)/5' adenosine monophosphate-activated protein kinase (AMPK) family of kinases. HUNK has been found to play a role in breast cancer metastasis. However, conflicting reports indicate HUNK is a metastasis promoting factor as well as an inhibiting factor. Our group recently provided evidence that supports the conclusion that HUNK is a metastasis promoting factor by showing that HUNK regulates breast cancer metastasis through phosphorylation of EGFR. Here, we summarize our findings and discuss their implications toward pharmacological targeting of HUNK in breast cancer.
一旦发生转移性疾病,乳腺癌就无法治愈。因此,识别促进和支持乳腺癌转移的因素对于理解如何从药理学角度针对这一过程至关重要。激素上调的神经相关激酶(HUNK)是一种丝氨酸/苏氨酸蛋白激酶,与蔗糖非发酵-1(Snf-1)/5'-单磷酸腺苷激活蛋白激酶(AMPK)激酶家族相关。已发现HUNK在乳腺癌转移中起作用。然而,相互矛盾的报道表明,HUNK既是转移促进因子,也是抑制因子。我们的研究小组最近提供了证据,支持HUNK是转移促进因子这一结论,即表明HUNK通过表皮生长因子受体(EGFR)的磷酸化来调节乳腺癌转移。在此,我们总结我们的发现,并讨论它们对乳腺癌中HUNK的药理学靶向治疗的意义。